Prosecution Insights
Last updated: November 11, 2026
Application No. 18/712,444

PROFILE AND MODULE FOR USE IN PHOTOBIOREACTOR

Non-Final OA §112
Filed
May 22, 2024
Priority
Nov 23, 2021 — DK PA202101111 +2 more
Examiner
FISHER, BRITTANY I
Art Unit
1796
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Algiecel Aps
OA Round
1 (Non-Final)
84%
Grant Probability
Favorable
1-2
OA Rounds
4m
Est. Remaining
97%
With Interview

Examiner Intelligence

Grants 84% — above average
84%
Career Allowance Rate
459 granted / 544 resolved
+19.4% vs TC avg
Moderate +13% lift
Without
With
+12.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
41 currently pending
Career history
589
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
44.9%
+4.9% vs TC avg
§102
27.6%
-12.4% vs TC avg
§112
21.1%
-18.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 544 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Drawings The drawings were received on May 22, 2024. These drawings are accepted. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-14 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. With respect to claim 1, there is an initial recitation of “at least 4 planes” in line 2, and then a recitation of “at least one of the 4 planes” in line 4. It is unclear if the applicant is now defining that the elongated element only has 4 (different) planes from the original recited “at least 4 planes,” of if this is a typographical error (“…is placed on one of the at least 5 planes of the elongated element…”). Prior art that teaches either interpretation will suffice to meet the claimed language. Clarification is requested. Claims 2-5 and 7 are ultimately dependent upon claim 1 and inherit the same deficiency. With respect to claim 6, there is an initial recitation of “at least 4 planes” in line 2, and then a recitation of “at least one of the 4 planes” in lines 4-5. It is unclear if the applicant is now defining that the elongated element only has 4 (different) planes from the original recited “at least 4 planes,” of if this is a typographical error (“…is placed on one of the at least 5 planes of the elongated element…”). Prior art that teaches either interpretation will suffice to meet the claimed language. Clarification is requested. Claims 8 and 12-14 are ultimately dependent upon claim 6 and inherit the same deficiency. Claim 9 recites the limitation "the 4 planes" in line 5. There is insufficient antecedent basis for this limitation in the claim. Claims 10 and 11 are ultimately dependent upon claim 9 and inherit the same deficiency. The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claim 7 is rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Claim 7 refers to “the module” but there is no recitation of which module the claim is referring to (reference to claim 6 was removed). Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Allowable Subject Matter Claims 1-6 and 8-14 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: The closest cited prior art of reference is to Spicer et al (US 2015/0225684 A1), which discloses a profile (gimbal arrangement depicted in Figs. 7a-b, See Para. 0160) comprising an elongated element (suspended bioreactor box 53, See Figs. 7a-b) extending in a longitudinal direction along a centre line (C) and at least 4 planes (each wall of the box and the base, See Fig. 7a reproduced below) extending in the longitudinal direction of the elongated element (2) and surrounding the centre line (center point equally between all walls of the box, See Fig. 7a) of the elongated element, wherein a light source (light source 9, See Para. 0079 and Fig. 2a) is positioned on at least one of the 4 planes of the box (light source is positioned at the base wall of the box), wherein the elongated element comprises a hollow cavity (interior of the box 53 is arranged to enclose the mechanism of the bioreactor) extending throughout the length of the elongated element and wherein the hollow cavity is adapted to hold a fluid, such as water or the like (box is designed to hold culture vessel 2, which receives an aqueous medium, See Paras. 0017, 0068-0069, and 0134). PNG media_image1.png 527 729 media_image1.png Greyscale Fig. 7a (reproduced) However, Spicer fails to disclose or depict that the light source is positioned on one of the at least one 4 planes extending in the longitudinal direction. Rather, Spicer discloses and depicts that the at least one light source is placed on the bottom wall/base plane of the box. Spicer also does not disclose or teach the module of claim 6, further comprising at least two reactor tubes and fastening means locking the reactor tube in position relative to the at least one profiles; and the photobioreactor of claim 12 comprising the structure of the module of claim 6. Citation of Pertinent Prior Art The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: KR 2019/0094622 A (provided by applicant in IDS filed 8/23/2024) discloses a set of four cylindrical bioreactor containers having a light emitting source in their middle, having a square section and elongated to the size of the surrounding bioreactors. The structure holding the light emitting part and the four chambers is a support basis structure, upon which all 5 pieces are mounted, not an elongated structure. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to BRITTANY I FISHER whose telephone number is (469)295-9182. The examiner can normally be reached IFP. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, James Lin can be reached at (571) 272-8902. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BRITTANY I FISHER/Examiner, Art Unit 1796 September 19, 2026
Read full office action

Prosecution Timeline

May 22, 2024
Application Filed
Sep 23, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12782370
GLOBAL TEST FOR DETERMINING THE STATUS OF THE BLOOD COAGULATION SYSTEM
3y 8m to grant Granted Nov 03, 2026
Patent 12768829
METHOD OF DETECTING THE PRESENCE OR ABSENCE OF A CLOT IN A LIQUID SAMPLE ANALYZER
4y 10m to grant Granted Oct 20, 2026
Patent 12768768
HIGH-EFFICIENCY OPTICAL DETECTION OF PARTICLES IN MICRO-CAPILLARIES
3y 9m to grant Granted Oct 20, 2026
Patent 12761127
ISOLATION DEVICE AND ISOLATION METHOD
4y 5m to grant Granted Oct 13, 2026
Patent 12754128
METHODS FOR COMPACT MULTI-COLOR FLOW CYTOMETERS HAVING COMPACT DETECTION MODULES
5y 2m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
84%
Grant Probability
97%
With Interview (+12.7%)
2y 9m (~4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 544 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month